Pyrimethamine 12.5mg + Sulphadoxine 250mg Suspension Franchise in Ahmedabad

Antimalarial Combination Therapy Supplier in Mumbai

Pyrethon Suspension Distributor in Delhi

Malaria Treatment Syrup Franchise Opportunity in Bangalore

Antimalarial Suspension Stockist in Hyderabad
Pyrimethamine + Sulphadoxine Suspension Export & Manufacturing in Chandigarh

Home/Products /pyrimethamine-12-5mg-sulphadoxine-250mg-syrup

About the Product

Description


Pyrethon Suspension contains Pyrimethamine 12.5mg + Sulphadoxine 250mg, a fixed-dose antimalarial combination indicated for the treatment and prophylaxis of Plasmodium falciparum and other susceptible malaria infections. It helps in clearing blood-stage parasites and preventing disease recurrence.

Pyrimethamine inhibits folate metabolism in the malaria parasite, while Sulphadoxine acts as a synergistic antimicrobial, enhancing parasite clearance. The combination ensures high efficacy, rapid symptom resolution, and reduced risk of resistance.

For distributors and healthcare suppliers, Pyrethon Suspension is a high-demand antimalarial product, widely used in hospitals, pediatric clinics, endemic regions, and public health malaria control programs. Seasonal malaria incidence and preventive health measures contribute to consistent demand.

Adding Pyrethon Suspension to your antimalarial therapy segment creates strong opportunities in pharmacies, hospitals, clinics, export markets, and third-party manufacturing. Its proven efficacy, prescriber trust, and essential role in malaria management make it a valuable addition to pharmaceutical distribution portfolios.

Common side effects may include nausea, vomiting, headache, or mild gastrointestinal discomfort. Rare but serious side effects include severe allergic reactions, skin rashes, blood disorders (like anemia or leukopenia), and liver toxicity. Patients should seek immediate medical attention if severe or unusual symptoms occur.

Pyrethon Suspension is indicated for the treatment and prophylaxis of malaria caused by Plasmodium falciparum and other susceptible Plasmodium species, as prescribed by a healthcare professional.

Pyrethon Suspension should be taken exactly as prescribed, with doses carefully measured using a calibrated device. Screening for glucose-6-phosphate dehydrogenase (G6PD) deficiency may be recommended in certain cases. Patients should inform their doctor about liver, kidney, or blood disorders before use.

Store Pyrethon Suspension in a cool, dry place away from direct sunlight. Keep out of reach of children, shake well before use, and do not use beyond the expiry date printed on the label.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Pyrimethamine 12.5mg + Sulphadoxine 250mg Syrup in the PCD pharma franchise market?

Pyrimethamine 12.5mg + Sulphadoxine 250mg Syrup has demand in the anti-infective, pediatric, and tropical medicine segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on specialty anti-infective and pediatric portfolios.

Why should medical distributors include Pyrimethamine + Sulphadoxine Syrup in their product range?

Medical distributors and agencies can benefit from demand for specialized antimalarial therapy under strict medical supervision. Pyrimethamine 12.5mg and Sulphadoxine 250mg work together as an antimalarial combination used in specific malaria treatment protocols Commonly prescribed for the treatment of susceptible malaria infections as recommended by healthcare professionals and treatment guidelines The combination acts by inhibiting key metabolic pathways required for parasite growth and survival Syrup formulation provides convenient administration, especially for pediatric patients and individuals who have difficulty swallowing tablets Requires careful dosing and adherence to prescribed treatment regimens Frequently utilized in hospitals, pediatric clinics, and healthcare institutions involved in infectious disease management Widely prescribed by pediatricians, physicians, and infectious disease specialists This strengthens a comprehensive anti-infective and pediatric care portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this product?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Pyrimethamine 12.5mg + Sulphadoxine 250mg Syrup with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from specialty healthcare market opportunities, institutional demand, reliable supply chain support, repeat procurement requirements, and attractive margins in the anti-infective segment.

How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, and wholesalers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality pharmaceutical products, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.